Annual revenue rose from KRW 33.4 billion in 2022 to KRW 34.1 billion in 2023 (up 2.2% year on year), KRW 125.9 billion in 2024 (up 268.7%), and KRW 141.6 billion in 2025 (up 12.4%). Revenue increased for three consecutive years from 2023 to 2025, and 2025 was the largest year in the 2022 to 2025 period.
Licensing revenue for 2025 was reported at KRW 121.2 billion at the March 31, 2026 investor briefing. Operating losses were KRW 50.4 billion in 2022, KRW 80.8 billion in 2023, KRW 20.9 billion in 2024, and KRW 106.5 billion in 2025, a loss in each of the four years from 2022 to 2025.
The operating margin was -16.6% in 2024, the smallest loss ratio in the period, and worsened to -75.2% in 2025. Revenue growth did not narrow losses mainly because of R&D. R&D expenses for 2025 rose 72.5% year on year to KRW 195.7 billion.
Net profit attributable to controlling shareholders turned to a KRW 7.8 billion profit in 2024 and returned to a KRW 91.6 billion loss in 2025. In 2024, the company posted a net profit despite an operating loss of KRW 20.9 billion, meaning non-operating items more than offset the operating loss.
Operating cash flow moved from KRW 78.5 billion in 2024 to negative KRW 124.5 billion in 2025.
Quarterly revenue was KRW 16 billion in the fourth quarter of 2025, KRW 35.9 billion in the first quarter of 2026, KRW 5.53 billion in the second quarter of 2026, and KRW 14.5 billion in the third quarter of 2026, swinging widely.
Because the timing and recognition period of upfront fees and milestones shift, quarterly revenue is adjusted from period to period. Third-quarter 2026 revenue fell 64.9% from KRW 41.4 billion a year earlier, largely reflecting a base effect from a KRW 15.5 billion upfront fee recognized in the third quarter of 2025.
Net losses attributable to controlling shareholders totaled KRW 226.1 billion over the last four quarters, from the fourth quarter of 2025 through the third quarter of 2026.